NEW YORK (GenomeWeb) – The New York Genome Center has named Harold Swerdlow its VP of Technology Innovation.

In the role, he will be responsible for developing technologies to be used in genomics research and in clinical applications, including microfluidic tools for reducing the cost of single-cell and other DNA preparation methods for next-generation sequencing.

Swerdlow formerly was head of R&D at the Wellcome Trust Sanger Institute, he formerly was chief technology officer at Dolomite, and he was senior director of research at Solexa.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.